194 related articles for article (PubMed ID: 38512420)
1. Tumor treating fields suppress tumor cell growth and neurologic decline in models of spinal metastases.
Ledbetter D; de Almeida RAA; Wu X; Naveh A; Patel CB; Gonzalez Q; Beckham TH; North R; Rhines L; Li J; Ghia A; Aten D; Tatsui C; Alvarez-Breckenridge C
JCI Insight; 2024 Mar; 9(9):. PubMed ID: 38512420
[TBL] [Abstract][Full Text] [Related]
2. Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.
Voloshin T; Kaynan N; Davidi S; Porat Y; Shteingauz A; Schneiderman RS; Zeevi E; Munster M; Blat R; Tempel Brami C; Cahal S; Itzhaki A; Giladi M; Kirson ED; Weinberg U; Kinzel A; Palti Y
Cancer Immunol Immunother; 2020 Jul; 69(7):1191-1204. PubMed ID: 32144446
[TBL] [Abstract][Full Text] [Related]
3. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
[TBL] [Abstract][Full Text] [Related]
4. An orthotopic murine model of human spinal metastasis: histological and functional correlations.
Tatsui CE; Lang FF; Gumin J; Suki D; Shinojima N; Rhines LD
J Neurosurg Spine; 2009 Jun; 10(6):501-12. PubMed ID: 19558282
[TBL] [Abstract][Full Text] [Related]
5. Orthotopic murine model of a primary malignant bone tumor in the spine: functional, bioluminescence, and histological correlations.
Fahim DK; Tatsui CE; Suki D; Gumin J; Lang FF; Rhines LD
J Neurosurg Spine; 2014 Sep; 21(3):378-85. PubMed ID: 24971476
[TBL] [Abstract][Full Text] [Related]
6. Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo.
Voloshin T; Munster M; Blatt R; Shteingauz A; Roberts PC; Schmelz EM; Giladi M; Schneiderman RS; Zeevi E; Porat Y; Bomzon Z; Urman N; Itzhaki A; Cahal S; Kirson ED; Weinberg U; Palti Y
Int J Cancer; 2016 Dec; 139(12):2850-2858. PubMed ID: 27561100
[TBL] [Abstract][Full Text] [Related]
7. Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines.
Karanam NK; Srinivasan K; Ding L; Sishc B; Saha D; Story MD
Cell Death Dis; 2017 Mar; 8(3):e2711. PubMed ID: 28358361
[TBL] [Abstract][Full Text] [Related]
8. Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Leal T; Kotecha R; Ramlau R; Zhang L; Milanowski J; Cobo M; Roubec J; Petruzelka L; Havel L; Kalmadi S; Ward J; Andric Z; Berghmans T; Gerber DE; Kloecker G; Panikkar R; Aerts J; Delmonte A; Pless M; Greil R; Rolfo C; Akerley W; Eaton M; Iqbal M; Langer C;
Lancet Oncol; 2023 Sep; 24(9):1002-1017. PubMed ID: 37657460
[TBL] [Abstract][Full Text] [Related]
9. Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models.
Jian C; Tu MJ; Ho PY; Duan Z; Zhang Q; Qiu JX; DeVere White RW; Wun T; Lara PN; Lam KS; Yu AX; Yu AM
Oncotarget; 2017 May; 8(19):30742-30755. PubMed ID: 28415566
[TBL] [Abstract][Full Text] [Related]
10. Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs.
Kirson ED; Giladi M; Gurvich Z; Itzhaki A; Mordechovich D; Schneiderman RS; Wasserman Y; Ryffel B; Goldsher D; Palti Y
Clin Exp Metastasis; 2009; 26(7):633-40. PubMed ID: 19387848
[TBL] [Abstract][Full Text] [Related]
11. A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells.
Talbot LJ; Chabot A; Funk A; Nguyen P; Wagner J; Ross A; Tillman H; Davidoff A; Gottschalk S; DeRenzo C
Front Immunol; 2021; 12():691741. PubMed ID: 34211478
[TBL] [Abstract][Full Text] [Related]
12. Metastatic human breast cancer to the spine produces mechanical hyperalgesia and gait deficits in rodents.
Sarabia-Estrada R; Ruiz-Valls A; Guerrero-Cazares H; Ampuero AM; Jimenez-Estrada I; De Silva S; Bernhardt LJ; Goodwin CR; Ahmed AK; Li Y; Phillips NA; Gokaslan ZL; QuiƱones-Hinojosa A; Sciubba DM
Spine J; 2017 Sep; 17(9):1325-1334. PubMed ID: 28412561
[TBL] [Abstract][Full Text] [Related]
13. Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models.
Mumblat H; Martinez-Conde A; Braten O; Munster M; Dor-On E; Schneiderman RS; Porat Y; Voloshin T; Davidi S; Blatt R; Shteingauz A; Tempel-Brami C; Zeevi E; Lajterer C; Shmueli Y; Danilov S; Haber A; Giladi M; Weinberg U; Kinzel A; Palti Y
Lung Cancer; 2021 Oct; 160():99-110. PubMed ID: 34482104
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of Doxorubicin with TTFields and radiation: newer approaches to combat lung cancer.
Lee WS; Kim EH
Am J Cancer Res; 2022; 12(6):2673-2685. PubMed ID: 35812042
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields.
Chang E; Pohling C; Beygui N; Patel CB; Rosenberg J; Ha DH; Gambhir SS
J Neurooncol; 2017 Sep; 134(2):259-268. PubMed ID: 28681243
[TBL] [Abstract][Full Text] [Related]
16. The dielectric properties of skin and their influence on the delivery of tumor treating fields to the torso: a study combining in vivo measurements with numerical simulations.
Hershkovich HS; Urman N; Yesharim O; Naveh A; Bomzon Z
Phys Med Biol; 2019 Sep; 64(18):185014. PubMed ID: 31323651
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer.
Pless M; Droege C; von Moos R; Salzberg M; Betticher D
Lung Cancer; 2013 Sep; 81(3):445-450. PubMed ID: 23891283
[TBL] [Abstract][Full Text] [Related]
18. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
19. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.
Wang Y; Pandey M; Ballo MT
Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292
[TBL] [Abstract][Full Text] [Related]
20. Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model.
Barsheshet Y; Voloshin T; Brant B; Cohen G; Koren L; Blatt R; Cahal S; Haj Khalil T; Zemer Tov E; Paz R; Klein-Goldberg A; Tempel-Brami C; Jacobovitch S; Volodin A; Kan T; Koltun B; David C; Haber A; Giladi M; Weinberg U; Palti Y
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]